Top compounds associated with response to FBXO31


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.05
mRNA austocystin d CTRPv2 pan-cancer AAC -0.071 0.05
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.064 0.06
mRNA paclitaxel gCSI pan-cancer AAC -0.1 0.06
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.06
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.067 0.07
mRNA pac-1 CTRPv2 pan-cancer AAC 0.065 0.07
mRNA PF-3758309 CTRPv2 pan-cancer AAC 0.08 0.07
mRNA AZD-7545 CTRPv2 pan-cancer AAC -0.065 0.07
Download CSV